156 related articles for article (PubMed ID: 31012542)
1. Treatment of advanced pediatric renal cell carcinoma.
Ambalavanan M; Geller JI
Pediatr Blood Cancer; 2019 Aug; 66(8):e27766. PubMed ID: 31012542
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
[TBL] [Abstract][Full Text] [Related]
3. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
[TBL] [Abstract][Full Text] [Related]
5. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
7. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.
Geller JI; Ehrlich PF; Cost NG; Khanna G; Mullen EA; Gratias EJ; Naranjo A; Dome JS; Perlman EJ
Cancer; 2015 Jul; 121(14):2457-64. PubMed ID: 25845370
[TBL] [Abstract][Full Text] [Related]
8. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
9. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; St-Hilaire PA; Tian Z; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
World J Urol; 2021 Feb; 39(2):461-472. PubMed ID: 32253579
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome for metastatic papillary renal cell carcinoma patients.
Ronnen EA; Kondagunta GV; Ishill N; Spodek L; Russo P; Reuter V; Bacik J; Motzer RJ
Cancer; 2006 Dec; 107(11):2617-21. PubMed ID: 17083126
[TBL] [Abstract][Full Text] [Related]
12. Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.
Liu N; Wang Z; Gan W; Xiong L; Miao B; Chen X; Guo H; Li D
PLoS One; 2016; 11(11):e0166897. PubMed ID: 27893792
[TBL] [Abstract][Full Text] [Related]
13. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.
Geller JI; Dome JS
Cancer; 2004 Oct; 101(7):1575-83. PubMed ID: 15378495
[TBL] [Abstract][Full Text] [Related]
14. Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma.
Launay-Vacher V; Ayllon J; Janus N; Medioni J; Deray G; Isnard-Bagnis C; Oudard S
Urol Oncol; 2011; 29(5):492-4. PubMed ID: 19914102
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.
Choueiri TK; Plantade A; Elson P; Negrier S; Ravaud A; Oudard S; Zhou M; Rini BI; Bukowski RM; Escudier B
J Clin Oncol; 2008 Jan; 26(1):127-31. PubMed ID: 18165647
[TBL] [Abstract][Full Text] [Related]
16. The molecular characterization and therapeutic strategies of papillary renal cell carcinoma.
Chen Q; Cheng L; Li Q
Expert Rev Anticancer Ther; 2019 Feb; 19(2):169-175. PubMed ID: 30474436
[No Abstract] [Full Text] [Related]
17. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients.
Onishi T; Ohishi Y; Goto H; Suzuki M; Miyazawa Y
BJU Int; 1999 Jun; 83(9):937-43. PubMed ID: 10368232
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
[TBL] [Abstract][Full Text] [Related]
19. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
20. Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.
Onishi T; Oishi Y; Goto H; Tomita M; Abe K; Sugaya S
Int J Urol; 2001 Jun; 8(6):268-74. PubMed ID: 11389741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
